Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Marcela V. Maus, M.d.,ph.d.

Clinical trials sponsored by Marcela V. Maus, M.d.,ph.d., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Engineered immune cells take on glioblastoma in early trial Results expected Sep 2026 (estimated)
  • Double-targeted cell therapy takes on hard-to-treat lymphomas Results expected Jan 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 5 Not yet finished but already full! 1 Completed 1
Sort by
  • Can a common arthritis drug tame CAR-T's dangerous side effects?

    Symptom relief Completed

    This phase 2 trial tested whether adding the drug anakinra (Kineret) to standard CAR-T cell therapy could prevent nerve toxicity in 15 people with relapsed or refractory non-Hodgkin lymphoma. Participants received anakinra injections for a week alongside their CAR-T infusion. The…

    Phase 2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Symptom relief

    Last updated Jun 27, 2026 07:59 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space